- Home
- Publications
- Publication Search
- Publication Details
Title
Review: Escalating immunotherapy of multiple sclerosis
Authors
Keywords
-
Journal
Therapeutic Advances in Neurological Disorders
Volume 1, Issue 3, Pages 181-192
Publisher
SAGE Publications
Online
2008-11-05
DOI
10.1177/1756285608098359
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Use of Disease-Modifying Agents in Multiple Sclerosis - by the Canadian Network of MS Clinics
- (2014) Paul O’Connor CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- Systematic Review: Comparative Effectiveness and Harms of Disease-Modifying Medications for Rheumatoid Arthritis
- (2013) Katrina E. Donahue et al. ANNALS OF INTERNAL MEDICINE
- Magnetization transfer ratio evolution with demyelination and remyelination in multiple sclerosis lesions
- (2008) Jacqueline T. Chen et al. ANNALS OF NEUROLOGY
- Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase I trial
- (2008) Amit Bar-Or et al. ANNALS OF NEUROLOGY
- Therapeutic outcome 3 years after switching of immunomodulatory therapies in patients with relapsing–remitting multiple sclerosis in Argentina
- (2008) A. Carrá et al. EUROPEAN JOURNAL OF NEUROLOGY
- Treating multiple sclerosis with monoclonal antibodies
- (2008) Mathias Buttmann et al. Expert Review of Neurotherapeutics
- Combination therapies in multiple sclerosis
- (2008) Ralf Gold JOURNAL OF NEUROLOGY
- Intense immunosuppression in patients with rapidly worsening multiple sclerosis: treatment guidelines for the clinician
- (2008) Aaron Boster et al. LANCET NEUROLOGY
- Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- The B Cell — Old Player, New Position on the Team
- (2008) Henry F. McFarland NEW ENGLAND JOURNAL OF MEDICINE
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Natalizumab: increased vigilance is required in treating patients with multiple sclerosis
- (2008) Michael K. Racke et al. Therapeutic Advances in Neurological Disorders
- Natalizumab: benefit outweighs risk in selected patients with multiple sclerosis
- (2008) J. Theodore Phillips et al. Therapeutic Advances in Neurological Disorders
- Mitoxantrone as induction treatment in aggressive relapsing remitting multiple sclerosis: treatment response factors in a 5 year follow-up observational study of 100 consecutive patients
- (2007) E. Le Page et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now